Areas of experience include:

• Rheumatology
• Rheumatoid arthritis
• Osteoarthritis
• Osteoporosis
• Lupus
• Cardiovascular disease
• Hypercholesterolemia
• Hypertension
• Sleep disorders
• Smoking cessation
• Obesity
• Dermatology
• Psoriasis
• Migraine
• Vaccine
• HIV Vaccine
• Flu Vaccine

Roy M. Fleischmann, M.D.
Medical Director

Dr. Fleischmann is a clinical professor in the Department of Internal Medicine at the University of Texas Southwestern Medical Center (UTSMC) and is in private practice at Rheumatology Associates in Dallas. He has served as chief of the Division of Rheumatology at UTSMC University Hospitals' St. Paul, Dallas, since 1978. Dr. Fleischmann has been the co-medical director of Metroplex Clinical research Center since 1984.He received his Doctor of Medicine (M.D.) from State University of New York, Downstate Medical Center, in 1969, before completing his residency in internal medicine at the Mt. Sinai Hospital, New York City, and his fellowship in rheumatology at the College of Physicians and Surgeons, Columbia University, New York City.

He received his Doctor of Medicine (M.D.) from State University of New York, Downstate Medical Center, in 1969, before completing his residency in internal medicine at the Mt. Sinai Hospital, New York City, and his fellowship in rheumatology at the College of Physicians and Surgeons, Columbia University, New York City.

He is a diplomate of the American Board of Internal Medicine and is a fellow of the American College of Rheumatology. He has served on the finance committee of the American College of Rheumatology and the fund-raising committee of the Research and Education Foundation (REF) of the American College of Rheumatology. He has previously served on the board of directors and the executive committee of the North Texas Arthritis Foundation. He has been president of the Texas Rheumatism Society and has sat on the governing board of the Texas Rheumatism Association. He has been a consultant to pharmacological companies in the areas of trial design, protocol development and CME development. He is a member of the Inflammation Research Association, the Associates of Clinical Pharmacology and the Drug Information Association. He has been involved in many clinical trials on treatments for osteoarthritis and rheumatoid arthritis and has published more than 60 peer-reviewed articles in these areas. Dr. Fleischmann has been voted one of the Best Doctors in Dallas as well as Texas Super Doctors.

Stanley B. Cohen, M.D.
Medical Director

Dr. Cohen is a clinical professor in the Department of Internal Medicine at the University of Texas Southwestern Medical School (UTSMS) and is in private practice at Rheumatology Associates in Dallas. He is associate director of the Division of Rheumatology at UTSMC University Hospitals' St. Paul and medical director of Metroplex Clinical Research Center in Dallas. Dr. Cohen is actively involved in teaching rheumatology fellows and residents during their clinical rotations in the office.

Dr. Cohen graduated Phi Beta Kappa with a degree in biology from the University of Virginia and received his Doctor of Medicine (M.D.) with honors from the University of Alabama School of Medicine in Birmingham, where he was inducted into Alpha Omega Alpha Honor Medical Society. He then completed an internship and residency in internal medicine at Parkland Memorial Hospital in Dallas and a fellowship in rheumatology at St. Paul Medical Center/Southwestern Medical School in Dallas. Dr. Cohen is board certified in Rheumatology and internal medicine and has served as co-medical director of Metroplex Clinical Research since 1984.

A fellow of the American College of Rheumatology, Dr. Cohen was past-chairman of the board of the North Texas Arthritis Foundation (AF) and was honored with the AF Medical Profession Award in 1994. He was president of the American College of Rheumatology Research and Education Foundation from 2000 to 2002 and served on the board of directors of the American College of Rheumatology from 2001 to 2004. He was previously on the Medical Advisory Board of Directors of the Harold C. Simmons Arthritis Center at the University of Texas Southwestern Medical School. Dr. Cohen is presently President of the American College of Rheumatology and a member of the University of Texas Southwestern Medical School CME Executive Committee.

He has served as a consultant to the pharmaceutical industry on protocol development in rheumatoid arthritis, glucocorticoid induced osteoporosis and disease modification in osteoarthritis, as well as medical advisory boards and data safety monitoring committees. Dr. Cohen has been an author or co-author of book chapters, articles and abstracts that have been published in many leading journals and presented at national and international medical and scientific symposia. He also received the Howard. C. Coggeshall Lifetime Achievement Service Award from the North Texas Arthritis Foundation in 2006 for longtime support of the Foundation and its programs.

Our staff is highly trained and includes 8 certified Coordinators, 2 ACLS certified critical care staff, 3 phlebotomists , 2 quality control employees monitoring all visits 3 full time recruiters and a regulatory specialist, as well as a distinguished contingent of eleven board certified rheumatologists. Medical directors Roy M. Fleischmann, M.D., and Stanley B. Cohen, M.D., have 50 years of combined clinical research experience and, between them, have published 100 scientific papers and co-authored four medical books. They are lecturers on the subjects of research and treatment of arthritis and osteoporosis and serve as advisors to major pharmaceutical companies.

MCRC is affiliated with Rheumatology Associates with a data base of 40,000 patients with autoimmune disease. We also maintain a database of over 20,000 participants that have either participated in a study or expressed an interest. Our recruiters are very active in the community and are constantly adding to our data base of volunteers.

Dermatology/Plastic Surgery
Musculoskeletal
Rheumatology